Article Text

Download PDFPDF
Discordant MRI/FDG- PET imaging for the diagnosis of borderline ovarian tumors
  1. D. C. Jung*,
  2. H. J. Choi*,
  3. W. Ju,,
  4. S. C. Kim, and
  5. K-G. Choi,§
  1. *Department of Radiology, National Cancer Center, Goyang, Korea; and
  2. Department of Obstetrics and Gynecology,
  3. Medical Research Institute,
  4. § Department of Neurology, School of Medicine, Ewha Womans University, Seoul, Korea
  1. Address correspondence and reprint requests to: Woong Ju, MD, Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, 911-1 Mok-Dong, Yangchun-Ku, Seoul 158–710, South Korea. Email: goodmorning{at}ewha.ac.kr

Abstract

The objective of this study was to assess the role of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI–PET differences may help differentiate borderline from malignant ovarian tumors.

  • borderline ovarian tumor
  • MRI
  • PET

Statistics from Altmetric.com

Footnotes

  • D.C.J. and H.J.C. contributed equally to this work.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.